Enhanced activity of the CREB co-activator Crtc1 in LKB1 null lung cancer

Oncogene

Volumn 29, Issue 11, 2010, Pages 1672-1680

  Komiya, T ^a   Coxon, A ^a   Park, Y ^a   Chen, W D ^a   Zajac Kaye, M ^a   Meltzer, P ^a   Karpova, T ^a   Kaye, F J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Crtc1; LKB1; Lung cancer; Mect1 Torc1; NR4A2

Indexed keywords

NUCLEAR RECEPTOR RELATED FACTOR 1; PROTEIN CRTC2; PROTEIN KINASE LKB1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CRTC GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION; TUMOR GENE;

ADULT; BRAIN; CELL LINE, TUMOR; CELL NUCLEUS; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOBLOTTING; LUNG NEOPLASMS; MUTATION; NUCLEAR PROTEINS; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; ONCOGENE PROTEINS, FUSION; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE; TRANSCRIPTION FACTORS;

MUS;

EID: 77949654290     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.453     Document Type: Article

References (48)

1. Achcar RD, Nikiforova MN, Dacic S, Nicholson AG, Yousem SA. (2009). Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma. Hum Pathol 40: 854-860.
2. Behboudi A, Winnes M, Gorunova L, van den Oord JJ, Mertens F, Enlund F, et al. (2005). Clear cell hidradenoma of the skin-a third tumor type with a t(11;19)-associated TORC1-MAML2 gene fusion. Genes Chromosomes Cancer 43: 202-205.
3. Bittinger MA, McWhinnie E, Meltzer J, Iourgenko V, Latario B, Liu X, et al. (2004). Activation of cAMP response element-mediated gene expression by regulated nuclear transport of TORC proteins. Curr Biol 14: 2156-2161.
4. Camelo-Piragua SI, Habib C, Kanumuri P, Lago CE, Mason HS, Otis CN. (2009). Mucoepidermoid carcinoma of the breast shares cytogenetic abnormality with mucoepidermoid carcinoma of the salivary gland: a case report with molecular analysis and review of the literature. Hum Pathol 40: 887-892.
5. Carling D. (2006). LKB1: a sweet side to Peutz-Jeghers syndrome? Trends Mol Med 12: 144-147.
6. Cheng H, Liu P, Wang ZC, Zou L, Santiago S, Garbitt V, et al. (2009). SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis. Sci Signal 2: ra35.
7. Conkright MD, Canettieri G, Screaton R, Guzman E, Miraglia L, Hogenesch JB, et al. (2003). TORCs: transducers of regulated CREB activity. Mol Cell 12: 413-423.
8. Coxon A, Rozenblum E, Park YS, Joshi N, Tsurutani J, Dennis PA, et al. (2005). Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes. Cancer Res 65: 7137-7144.
9. Dentin R, Liu Y, Koo SH, Hedrick S, Vargas T, Heredia J, et al. (2007). Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature 449: 366-369.
10. Enlund F, Behboudi A, Andren Y, Oberg C, Lendahl U, Mark J, et al. (2004). Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumors. Exp Cell Res 292: 21-28.
11. Fu A, Screaton RA. (2008). Using kinomics to delineate signaling pathways: control of CRTC2/TORC2 by the AMPK family. Cell Cycle 7: 3823-3828.
12. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, et al. (2003). Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2: 28.
13. Hezel AF, Bardeesy N. (2008). LKB1; linking cell structure and tumor suppression. Oncogene 27: 6908-6919.
14. Holla VR, Mann JR, Shi Q, DuBois RN. (2006). Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer. J Biol Chem 281: 2676-2682.
15. Hong SP, Leiper FC, Woods A, Carling D, Carlson M. (2003). Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases. Proc Natl Acad Sci USA 100: 8839-8843.
16. Huang X, Wullschleger S, Shpiro N, McGuire VA, Sakamoto K, Woods YL, et al. (2008). Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice. Biochem J 412: 211-221.
17. Iourgenko V, Zhang W, Mickanin C, Daly I, Jiang C, Hexham JM, et al. (2003). Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells. Proc Natl Acad Sci USA 100: 12147-12152.
18. Ji H, Ramsey MR, Hayes DN, Fan C, McNamara K, Kozlowski P, et al. (2007). LKB1 modulates lung cancer differentiation and metastasis. Nature 448: 807-810.
19. Katajisto P, Vallenius T, Vaahtomeri K, Ekman N, Udd L, Tiainen M, et al. (2007). The LKB1 tumor suppressor kinase in human disease. Biochim Biophys Acta 1775: 63-75.
20. Katoh Y, Takemori H, Lin XZ, Tamura M, Muraoka M, Satoh T, et al. (2006). Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade. FEBS J 273: 2730-2748.
21. Kaye FJ. (2006). Emerging biology of malignant salivary gland tumors offers new insights into the classification and treatment of mucoepidermoid cancer. Clin Cancer Res 12: 3878-3881.
22. Kaye FJ. (2009). Mutation-associated fusion cancer genes in solid tumors. Mol Cancer Ther 8: 1399-1408.
23. Kazakov DV, Vanecek T, Belousova IE, Mukensnabl P, Kollertova D, Michal M. (2007). Skin-type hidradenoma of the breast parenchyma with t(11;19) translocation: hidradenoma of the breast. Am J Dermatopathol 29: 457-461.
24. Ke N, Claassen G, Yu DH, Albers A, Fan W, Tan P, et al. (2004). Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis. Cancer Res 64: 8208-8212.
25. Komiya T, Park Y, Modi S, Coxon A, Oh H, Kaye FJ. (2006). Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation. Oncogene 25: 6128-6132.
26. Kovacs KA, Steullet P, Steinmann M, Do KQ, Magistretti PJ, Halfon O, et al. (2007). TORC1 is a calcium-and cAMP-sensitive coincidence detector involved in hippocampal long-term synaptic plasticity. Proc Natl Acad Sci USA 104: 4700-4705.
27. Lennerz JK, Perry A, Mills JC, Huettner PC, Pfeifer JD. (2009). Mucoepidermoid Carcinoma of the Cervix: Another Tumor With the t(11;19)-associated CRTC1-MAML2 Gene Fusion. Am J Surg Pathol 33: 835-843
28. Li QX, Ke N, Sundaram R, Wong-Staal F. (2006). NR4A1, 2, 3-an orphan nuclear hormone receptor family involved in cell apoptosis and carcinogenesis. Histol Histopathol 21: 533-540.
29. Li S, Zhang C, Takemori H, Zhou Y, Xiong ZQ. (2009). TORC1 regulates activity-dependent CREB-target gene transcription and dendritic growth of developing cortical neurons. J Neurosci 29: 2334-2343.
30. Li X, Tai HH. (2009). Activation of Thromboxane A2 Receptors Induces Orphan Nuclear Receptor Nurr1 Expression and Stimulates Cell Proliferation in Human Lung Cancer Cells. Carcinogenesis 30: 1606-1613.
31. Lizcano JM, Goransson O, Toth R, Deak M, Morrice NA, Boudeau J, et al. (2004). LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J 23: 833-843.
32. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS. (2002). Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 16: 948-958.
33. Pei L, Waki H, Vaitheesvaran B, Wilpitz DC, Kurland IJ, Tontonoz P. (2006). NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nat Med 12: 1048-1055.
34. Ravnskjaer K, Kester H, Liu Y, Zhang X, Lee D, Yates 3rd JR, et al. (2007). Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression. EMBO J 26: 2880-2889.
35. Sanchez-Cespedes M. (2007). A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome. Oncogene 26: 7825-7832.
36. Sanchez-Cespedes M, Parrella P, Esteller M, Nomoto S, Trink B, Engles JM, et al. (2002). Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res 62: 3659-3662.
37. Screaton RA, Conkright MD, Katoh Y, Best JL, Canettieri G, Jeffries S, et al. (2004). The CREB coactivator TORC2 functions as a calcium-and cAMP-sensitive coincidence detector. Cell 119: 61-74.
38. Shah U, Sharpless NE, Hayes DN. (2008). LKB1 and lung cancer: more than the usual suspects. Cancer Res 68: 3562-3565.
39. Shaw RJ. (2009). Tumor suppression by LKB1: SIK-ness prevents metastasis. Sci Signal 2: pe55.
40. Shaw RJ, Bardeesy N, Manning BD, Lopez L, Kosmatka M, DePinho RA, et al. (2004). The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 6: 91-99.
41. Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, et al. (2005). The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310: 1642-1646.
42. Tiainen M, Ylikorkala A, Makela TP. (1999). Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest. Proc Natl Acad Sci USA 96: 9248-9251.
43. Tirado Y, Williams MD, Hanna EY, Kaye FJ, Batsakis JG, El-Naggar AK. (2007). CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior. Genes Chromosomes Cancer 46: 708-715.
44. Tonon G, Modi S, Wu L, Kubo A, Coxon AB, Komiya T, et al. (2003). t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet 33: 208-213.
45. Wallen-Mackenzie A, Mata de Urquiza A, Petersson S, Rodriguez FJ, Friling S, Wagner J, et al. (2003). Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells. Genes Dev 17: 3036-3047.
46. Wang B, Goode J, Best J, Meltzer J, Schilman PE, Chen J, et al. (2008). The insulin-regulated CREB coactivator TORC promotes stress resistance in Drosophila. Cell Metab 7: 434-444.
47. Wu L, Liu J, Gao P, Nakamura M, Cao Y, Shen H, et al. (2005). Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation. EMBO J 24: 2391-2402.
48. Zhou Y, Wu H, Li S, Chen Q, Cheng XW, Zheng J, et al. (2006). Requirement of TORC1 for late-phase long-term potentiation in the hippocampus. PLoS ONE 1: e16.